Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;21(8):1339-1340.
doi: 10.5664/jcsm.11798.

Pharmacological management of sleep apnea and obesity, a new frontier

Affiliations

Pharmacological management of sleep apnea and obesity, a new frontier

Pahnwat Tonya Taweesedt et al. J Clin Sleep Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have seen and approved the manuscript. The authors report no conflicts of interest.

Comment on

  • Commentary on Sevencan B, Steenackers N, van Laar ADE, et al. Evaluating the potential of metabolic drugs in obstructive sleep apnea and obesity: a narrative review. J Clin Sleep Med. 2025;21(8):1433–1444. doi:10.5664/jcsm.11682

Similar articles

References

    1. Hall KD , Kahan S . Maintenance of lost weight and long-term management of obesity . Med Clin North Am. 2018. ; 102 ( 1 ): 183 – 197 . - PMC - PubMed
    1. Noria SF , Shelby RD , Atkins KD , Nguyen NT , Gadde KM . Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment . Curr Diab Rep. 2023. ; 23 ( 3 ): 31 – 42 . - PMC - PubMed
    1. Sevencan B , Steenackers N , van Laar ADE , et al . Evaluating the potential of metabolic drugs in obstructive sleep apnea and obesity: a narrative review . J Clin Sleep Med. 2025. ; 21 (8):1433–1444. - PMC - PubMed
    1. Aronne LJ , Horn DB , Le Roux CW , et al. ; SURMOUNT-5 Trial Investigators . Tirzepatide as compared with semaglutide for the treatment of obesity [published online ahead of print, 2025. May 11]. N Engl J Med. - PubMed
    1. Neeland IJ , Eliasson B , Kasai T , et al. ; EMPA-REG OUTCOME Investigators . The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial . Diabetes Care. 2020. ; 43 ( 12 ): 3007 – 3015 . - PMC - PubMed

LinkOut - more resources